AzTrials
AzTrials

Dental PlaquePhase 2MGPNCT01142843

Preliminary Evidence of the Efficacy of a Mouthwash Containing 5% Propolis for the Control of Plaque and Gingivitis

A Phase 2 study testing green propolis mouthwash in people with Dental Plaque and Gingivitis, run by Federal University of Minas Gerais at 1 site in Brazil.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Mouthwash based on medicinal plants and propolis can be easily found in the Brazilian market even if it has not been tested in reliable clinical trials on its efficacy or possible unpleasant side effects like the ones which alter the hard and soft oral tissues. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Dental Plaque, Gingivitis
What is being tested?
green propolis mouthwash
How many people
25 participants
Where
1 siteBrazil
Study dates
Aug 2009to Mar 2010
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • age 18-60 years
  • generally good health
  • not pregnant nor breastfeeding
  • a minimum of 20 sound, natural teeth
  • a mean plaque index (PI) (Turesky modification of the Quigley-Hein Plaque Index, 1970) of at least 1.5 or more
  • a mean gingival index (GI) (Talbott modification Gingival Index of the Löe-Silness, 1977) of at least 1.0 or more
  • signing the terms of agreement

Who cannot join

  • Subjects with orthodontic appliances or removable prosthetics
  • Subjects with tumors of the soft or hard oral tissues
  • Subjects with advanced periodontal disease
  • Subjects that received antibiotic therapy 2 weeks before the start of the study
  • Subjects with hipersensibility to propolis confirmed

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Universidade Federal de Minas Gerais (UFMG)

    Belo Horizonte, Minas Gerais, 31270-901

Other trials in Brazil

About this study

Official title: Clinical Preliminary Evidence of the Efficacy of a Mouthwash Containing 5% Propolis for the Control of Plaque and Gingivitis: Phase II Study

Mouthwash based on medicinal plants and propolis can be easily found in the Brazilian market even if it has not been tested in reliable clinical trials on its efficacy or possible unpleasant side effects like the ones which alter the hard and soft oral tissues. The aim of this study was to obtain preliminary evidence of efficacy of an alcohol-free mouthwash containing 5% green propolis (MGP 5%) on the control of plaque and gingivitis. Were chosen twenty-five subjects that are UFMG employees and individuals who would begin treatment on an extension project called Supportive Periodontal Therapy at the Faculty of Dentistry of Federal University of Minas Gerais, Belo Horizonte, from August to December 2009. The subjects went through a dental prophylaxis before starting rinse. They were then instructed to rinse twice a day for a minute, immediately after brushing (morning and night), using the 10 ml of the MGP 5%. After 45 and 90 days using the product the individuals returned for a clinical evaluation which considered changes in the soft and hard oral tissues and involved collecting plaque and gingivitis indexes. On their last appointment the subjects answered a questionnaire about their level of appreciation and acceptability of the mouthwash. Compliance with the treatment was also evaluated through an attendance form. For the statistic analysis we used BioEstat 4.0 and Excel 2007.

Read the detailed description

The first reference to mouthrinse as a formal practice is credited to Chinese medicine, about 2700 B.C.E., to treatment the diseases of the gums (Fischman, 1997).

The gram-positive and gram-negative bacteria that compose oral biofilms produces many metabolites that induce gingival inflammation (that is, gingivitis). Gingivitis can lead to periodontitis, a condition in which gingival and bone tissues are destroyed. The majority of the population may not perform mechanical plaque removal sufficiently. Thus, antimicrobial mouthrinses that improve daily home care may provide an effective way of removing or controlling bacterial plaque to limit gingivitis and periodontitis (Haffajee et al., 2008).

The main indications are either the improvement of dental health (plaque and gingivitis elimination in particular) or the prevention of infections caused by bacteria of the oral cavity in specific situations, such as tooth extraction, intraoral surgical procedures or immune suppression due to cancer therapy or transplantation. The use of antimicrobial mouthrinses has been proposed to reduce the levels of oral bacteria, specially Streptococcus mutans (Kocak et al., 2009).

In fact, it has been shown that chemotherapeutic mouthrinses are an effective adjunct to regular brushing and flossing for patients with gingivitis, providing a clinically significant benefit in the reduction of plaque and gingivitis (Haffajee et al., 2008).

Propolis is a resinous substance collected by honeybees from buds and exudates of certain trees and plants, and stored inside their hives. It has been used in folk medicine from ancient times to treat various ailments (Kunimasa et al., 2009).

The action against microorganisms is an essential characteristic of propolis, and humans have used it for centuries for its pharmaceutical properties (Kalogeropoulos et al., 2009).

The antibacterial activity of propolis is reported due to flavonoids, aromatic acids and esters present in resins. Galangin, pinocebrin and pinostrobin are known as the flavonoids agents more effective against bacteria. Ferulic acid and caffeic acid also contribute to the bactericidal action of propolis (Marcucci, 1995). Thus, the purpose of this study was to show a preliminary evidence about the effect of an alcohol-free mouthwash containing 5% of green propolis for the control of plaque and gingivitis in subjects for three months.

Materials and Methods

Design study and Product tested

This was an interventional study of phase II for three months, follow up type, and was conducted at the Faculty of Dentistry of Federal University of Minas Gerais, Brazil, from August 2009 to April 2010.

The alcohol-free mouthwash containing 5% green propolis (MGP 5%) used in that study was handled according to our request by PharmaNéctar ® (Belo Horizonte), within the standards required by ANVISA (Brazil, 2000) and within the requirements of ISO 9001 and GMP International (Table 1).

Participants

Twenty five subjects, age varying from 18 to 60 years (median age 35,92 ±9,7), with generally good health, not pregnant nor breastfeeding, who met the following inclusion criteria, were included into the study: a minimum of 20 sound, natural teeth; a mean plaque index (PI) (Turesky modification of the Quigley-Hein Plaque Index, 1970) of at least 1.5; a mean gingival index (GI) (Talbott modification Gingival Index of the Löe-Silness, 1977) of at least 1.0. Subjects with orthodontic appliances or removable prosthetics, tumors of the soft or hard oral tissues, advanced periodontal disease, or that received antibiotic therapy 2 weeks before the start of the study or that presented hipersensibility to propolis were excluded. Third molars and those teeth with cervical restorations or prosthetic crowns were not included in the tooth count. The selection of participants was made by convenience, based especially on the availability for the study, along the study was conducted. All subjects read and signed informed consent forms before the start of the study. The protocol for the study was approved by the local ethical review committee (Committee of Bioethics in Research at the Federal University of Minas Gerais (COEP/UFMG - 0600/09).

Assessing mouthwash

The examination baseline consisted of a complete soft and hard tissues examination that was performed to register the condition of oral mucosa, so that any changes in the course of the study could be identified , making assessment to whether these changes could be related to the mouthrinse. The gingivitis of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual, of all elegible teeth was scored using the Talbott modification Gingival Index of the Löe-Silness - GI, 1977, in which the gum was scored on a four-point scale from 0 (absence of inflammation) to 3 ( severe inflammation). The supragingival plaque of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual, of all elegible teeth was scored using the Turesky modification of the Quigley-Hein Plaque Index - PI, 1970. Previously, disclosing with erythrosine 3% solution, plaque was scored on a six point scale from 0 (no plaque) to 5 (plaque covers two-thirds or more of the tooth surface). Of the mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, and distolingual, of all scorable teeth was scored using the Turesky modification of the Quigley-Hein Plaque Index - PI, 1970. There were also evaluated Severity Plaque Index and Severity Gingival Index (Palomo et al., 1989; Volpe et al.,1993). These index measured the rate of the surface that had high count of plaque (count similar to 3, 4, 5 of the modification Quigley-Hein Plaque Index, 1970) and high gingival index (count similar to 2,3 modification Gingival Index of the Löe-Silness, 1977.

These examinations were all repeated after 45 and 90 days of use of mouthrinse. After baseline examination, each subject received a complete oral prophylaxis, which included the removal of all supragingival plaque and calculus deposits. Soon after, the subjects received the 5% green propolis-containing mouthrinse alcohol-free (MGP 5%) and a toothbrush. They were instructed to brush their teeth as usual and to rinse with the 10mL of MGP 5%, twice a day, for one minute, right after their meals in the morning and at night. Participants were required not to use another mouthrinse throughout the study. When new supplies were issued, subjects returned their used materials, so that compliance to theproduct could be monitored.

Reproducibility of clinical examinations

All examinations were conducted by a single examiner trained to optimize the consistency of the study. Prior to the study, the adviser trained the dental examiner, as a "gold standard", directing him to introduce the periodontal probe, gently, into the gingival sulcus,, keeping the instrument parallel to the long axis of the tooth, sliding it from the distal to the mesial so delicately in the buccal and lingual surface of each evaluated tooth. For calibration, there was examined nine subjects not included in the study.

For the plaque index it was performed a theoretical calibration. Soon after, photos were used to obtain a standardization intra-examiner. The photos were exhibited by the adviser to the examiner that noted the values of plaque index corresponding to each picture. After 15 days, the same pictures were exposed to the examiner that noted again the values of plaque index. Next, the plaque index obtained in the first and second time was compared to verify the level of intra-examiner. Then, we obtained a kappa value of 0.73, considered a substantial estimate of reliability (Landis \& Koch, 1977).

Statistical Analysis

The statistical package BioEstat version 4.0 was used for data analysis in this study. The average adjusted in the baseline for both scores of the modified Plaque Index of Quigley-Hein (1970) and modified Gingival Index of Löe-Silness (1977) as for the corresponding severity scores, for being a non-parametric distribution, were compared through covariance analysis, by Friedman test for data obtained at 45 and 90 days of the study. All statistical tests of hypotheses had two strands and was considered a significance level of p< 0.05 (Allen et al. 1998; Arweiler et al., 2001).

Being tested
green propolis mouthwash
Keywords
clinical trial, mouthwash, green propolis, dental plaque, gingivitis
Medical subject headings
Dental Plaque, Gingivitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • green propolis mouthwashDrug

    Also called mouthrinse, Brazilian propolis, Baccharis dracunculifolia

    The subjects were instructed to brush their teeth as usual and to rinse with the 10mL of Mouthwash contain 5% Green Propolis, twice a day, for one minute, right after their meals in the morning and at night. The treatment was performed during three months

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Efficacy of a mouthwash containing 5% propolis for the control of gingivitis

    Difference in the Gingival Index scores between the start and the end of the study.

    Measured: 90 days

Secondary outcomes (1)
  1. Efficacy of a mouthwash containing 5% propolis for the control of plaque

    Difference in the Plaque Index scores between the start and the end of the study.

    Measured: 90 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jun 2010 (estimated)
  2. Study startAug 2009
  3. Primary completionOct 2009
  4. Study completionMar 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01142843
Sponsor's protocol ID
VSantos-UFMG
Acronym
MGP
Status last verified
May 2009
First submitted
10 Jun 2010
Last updated
2 Jul 2010
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing green propolis mouthwash in people with Dental Plaque and Gingivitis, run by Federal University of Minas Gerais at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jul 2010. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Efficacy of a mouthwash containing 5% propolis for the control of gingivitis (time frame: 90 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2010.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in